NEWS

Integra LifeSciences (Nasdaq:IART) announced today that it named Stuart M. Essig as its president and CEO, effective May 1. Essig, the company’s board chair, succeeds Mojdeh Poul in the corner office as he continues to serve as board chair. “Stuart brings unmatched...

Stuart Essig Appointed as Integra’s Next President and Chief Executive Officer Michael McBreen Appointed Chief Commercial Officer PRINCETON, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART), a...

JACKSONVILLE, Fla.—January 12, 2026—Availity, the nation’s largest real-time health information network, today announced that it has earned the 2025 Modern Healthcare Best in Business Award in the Cybersecurity category for Rapid Recovery, an innovative framework...

Executive team further strengthened with appointments of Teshtar Elavia to the newly created chief technology officer role, Michael Hutchinson as chief legal officer, and Kerri DiPietro as chief quality officer, representing decades of experience in the MedTech...

Michael Erickson, PhD, to Succeed Jay Mazelsky as President and CEO; Mazelsky to Serve as Executive Chair of the Board of Directors WESTBROOK, Maine--(BUSINESS WIRE)-- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today...

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 4, 2026-- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Stuart M. Essig, Ph.D. to its board of directors. “Stuart will be a great asset to our board of directors. He brings...

Combined company offers next-generation commercialization model that directly connects life sciences to payers and patients to accelerate access, improve affordability and transform drug value across the care continuum. Waltz Health Co-founder and CEO Mark Thierer...

Positions company for several new product launches and scaling of operations to meet rising demand globally $1 billion of new capital raised to refinance debt and fund accelerated growth Waltham, MA, March 10, 2025 – BVI Medical, a leading global ophthalmic device...